Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.0127 EUR
13.92 M EUR
108.35 M EUR
255.39 M
About Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class H
Sector
CEO
Da Jun Zhao
Headquarters
Shanghai
Website
Founded
1996
ISIN
CNE1000000W4
FIGI
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd. engages in research and development and commercialization of drugs. Its research and development platforms include genetic technical platform, photodynamic platform, nano technical platform and oral solid preparation platform. The company’s products include ALA on photodynamic technical platform, LIBOd on nano technical platform and all kinds of diagnostic reagents on diagnosis technology platform. Shanghai Fudan Zhangjiang Bio Pharmaceutical was founded by Jun Li, Hai Bo Wang and Da Jun Zhao on November 11, 1996 and is headquartered in Shanghai, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on LSX exchange Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class H stocks are traded under the ticker A0M4V0.
A0M4V0 stock hasn't changed in a week, the last month showed zero change in price, over the last year there was no change in Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class H price.
A0M4V0 stock is 0.00% volatile and has beta coefficient of 1.66. Track Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class H stock price on the chart and check out the list of the most volatile stocks — is Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class H there?
Yes, you can track Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class H financials in yearly and quarterly reports right on TradingView.
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class H is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
A0M4V0 net income for the last quarter is 2.01 M EUR, while the quarter before that showed 8.79 M EUR of net income which accounts for −77.13% change. Track more Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class H financial stats to get the full picture.
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class H dividend yield was 2.97% in 2023, and payout ratio reached 65.20%. The year before the numbers were 2.30% and 51.22% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jan 16, 2025, the company has 948.00 employees. See our rating of the largest employees — is Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class H on this list?
Like other stocks, A0M4V0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class H stock right from TradingView charts — choose your broker and connect to your account.